An engineered ACE2 decoy receptor can be administered by inhalation and potently targets the BA.1 and BA.2 omicron variants of SARS-CoV-2
Lianghui Zhang(Illinois College), Erik Procko(University of Illinois Urbana-Champaign)
Cited by 22
Related Papers
The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2
|bioRxiv (Cold Spring Harbor Laboratory)|2020|100
Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants
|Nature Chemical Biology|2022|89
An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants
|bioRxiv (Cold Spring Harbor Laboratory)|2020|32
Deep Mutagenesis of a Transporter for Uptake of a Non-Native Substrate Identifies Conformationally Dynamic Regions
|bioRxiv (Cold Spring Harbor Laboratory)|2021|17
Engineered receptors for human cytomegalovirus that are orthogonal to normal human biology
|PLoS Pathogens|2020|16